Quinn Opportunity Partners LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$231,000
-51.1%
7,0000.0%0.02%
-48.3%
Q2 2021$472,000
+19.2%
7,0000.0%0.03%
+16.0%
Q1 2021$396,000
-30.5%
7,0000.0%0.02%
-47.9%
Q4 2020$570,000
+14.2%
7,0000.0%0.05%
-9.4%
Q3 2020$499,000
-32.7%
7,000
-22.2%
0.05%
-43.0%
Q2 2020$741,0009,0000.09%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders